Published in Br J Cancer on June 10, 2008
Malignant pleural mesothelioma. J Clin Oncol (2009) 2.16
Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol (2008) 1.07
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients. Radiol Oncol (2012) 0.92
Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis (2013) 0.91
Chemotherapy and targeted therapies for unresectable malignant mesothelioma. Lung Cancer (2011) 0.91
Mesothelioma: a review. Ochsner J (2012) 0.86
First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial. Br J Cancer (2012) 0.84
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol (2003) 11.22
The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis (1961) 4.25
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol (2004) 3.72
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest (1995) 3.21
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol (1994) 2.66
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol (1999) 2.25
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest (1998) 2.18
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol (1998) 2.15
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol (1998) 1.91
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol (2006) 1.66
Pleural mesothelioma: little evidence, still time to do trials. Lancet (2004) 1.38
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol (2003) 1.37
Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol (2000) 1.35
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer (2004) 1.28
Assessment of tumor response in malignant pleural mesothelioma. Cancer Treat Rev (2007) 1.21
The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. J Thorac Oncol (2006) 1.15
Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer (2002) 1.13
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer (2002) 1.10
Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Lung Cancer (2004) 1.00
Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer (2003) 0.98
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. Ann Oncol (2004) 0.91
Emerging insights into the biology and therapy of malignant mesothelioma. Semin Oncol (2002) 0.90
Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer (2004) 0.89
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Cochrane Database Syst Rev (2007) 0.83
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program. Lung Cancer (2006) 0.83
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma. Lung Cancer (2005) 0.81
Malignant pleural mesothelioma. Ann Oncol (2006) 0.78
Current concepts in chemotherapy for malignant pleural mesothelioma. Clin Respir J (2008) 0.77
Autolytic enzymes and cell division of Escherichia coli. J Mol Biol (1969) 8.69
THE EFFECT OF POSTURE (STANDING) ON THE SERUM PROTEIN CONCENTRATION AND COLLOID OSMOTIC PRESSURE OF BLOOD FROM THE FOOT IN RELATION TO THE FORMATION OF EDEMA. J Clin Invest (1934) 7.55
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol (1997) 3.45
Perceptions of parental bonding in borderline patients. Am J Psychiatry (1989) 2.70
Structure of simian virus 40. II. Symmetry and components of the virus particle. Virology (1967) 2.62
Tamoxifen in advanced breast cancer. Cancer Treat Rev (1978) 2.53
Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology (1972) 2.26
Structure of simian virus 40. I. Purification and physical characterization of the virus particle. Virology (1967) 2.21
Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet (1998) 2.21
Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer (1993) 2.15
Properties of mouse leukemia viruses. VII. The major viral glycoprotein of friend leukemia virus. Isolation and physicochemical properties. Virology (1974) 2.09
Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care (2003) 2.07
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
CHANGES IN THE BLOOD AND CIRCULATION WITH CHANGES IN POSTURE. THE EFFECT OF EXERCISE AND VASODILATATION. J Clin Invest (1935) 1.89
[Production of substantial amounts of Friend leukemia virus by a suspension tissue culture line (Eveline suspension cells) (author's transl)]. Z Naturforsch C (1976) 1.69
Electron microscopical studies on the localisation of the different components of cell walls of gram-negative bacteria. Folia Microbiol (Praha) (1967) 1.68
Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58
Cardiac and paracardiac masses. Current opinion on diagnostic evaluation by magnetic resonance imaging. Eur Heart J (1998) 1.51
Uses and misuses of oxygen in hospitalized patients. Am J Med (1992) 1.41
Congenital malformations of the right atrium and the coronary sinus: an analysis based on 103 cases reported in the literature and two additional cases. Chest (2000) 1.41
Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol (1984) 1.36
Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells. Biochim Biophys Acta (1996) 1.32
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol (1989) 1.30
Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab (1997) 1.26
Evolution of canine information processing under conditions of natural and artificial selection. Z Tierpsychol (1980) 1.21
Post-mortem findings in harbour porpoises (Phocoena phocoena) from the German North and Baltic Seas. J Comp Pathol (2001) 1.19
Fine structure of influenza A2 (Singapore) as revealed by negative staining, freeze-drying and freeze-etching. J Gen Virol (1971) 1.19
Corneal amyloidosis. Br J Ophthalmol (1989) 1.18
Psychological determinants of a medical career. Can J Psychiatry (1983) 1.17
Increased coupling yields in solid phase peptide synthesis with a modified carbodiimide coupling procedure. Hoppe Seylers Z Physiol Chem (1972) 1.14
Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. Eur J Biochem (1997) 1.12
Properties of mouse leukemia viruses. II. Isolation of viral components. Virology (1972) 1.10
Influence of age and sex on exercise cardiac output. J Appl Physiol (1965) 1.08
Investigations on virus production in RSV mammalian tumours. J Gen Virol (1970) 1.05
Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Alcohol Alcohol (2001) 1.05
Breast cancer and thoracic metastases: review of 119 patients. Thorax (1983) 1.04
Electron microscopic observations on fd bacteriophage, its alkali denaturation products and its DNA. Virology (1970) 1.04
Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation (1997) 1.04
Structural organization of unique retrovirus-like particles budding from human teratocarcinoma cell lines. J Gen Virol (1983) 1.04
Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol (1981) 1.03
Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia. Eur J Clin Invest (2004) 1.02
The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer (1984) 1.02
Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer. Recent Results Cancer Res (1980) 1.02
AIDS--the responsibility of health workers to assume some degree of personal risk. West J Med (1986) 1.01
Developmental inhibitory gate controls the relay of activity to the superficial layers of the visual cortex. J Neurosci (2001) 1.01
Role of 1,25-dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat. J Nutr (1972) 1.00
The structure of group II adenoviruses. J Gen Virol (1967) 1.00
C-type particles produced by a permanent cell line from a leukemic pig. II. Physical, chemical, and serological characterization of the particles. Virology (1974) 0.99
Mn2+-sensitive, soluble adenylate cyclase in rat testis. Differentiation from other testicular nucleotide cyclases. Biochim Biophys Acta (1977) 0.99
Properties of mouse leukemia viruses. IV. Hemagglutination assay and characterization of hemagglutinating surface components. Virology (1973) 0.99
Biological activity of 1,25-dihydroxyvitamin D3 in the rat. Endocrinology (1973) 0.99
Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology (1979) 0.98
Enantiomer labelling, a method for the quantitative analysis of amino acids. J Chromatogr (1978) 0.97
Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clin Microbiol Infect (2004) 0.97
Monitoring lipid peroxidation by breath analysis: endogenous hydrocarbons and their metabolic elimination. Toxicol Appl Pharmacol (1980) 0.97
Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol (1996) 0.97
Glutathione S-transferase A1-1-catalysed conjugation of bay and fjord region diol epoxides or polycyclic aromatic hydrocarbons with glutathione. Carcinogenesis (1996) 0.97
Properties of mouse leukemia viruses. VI. The core of Friend virus; isolation and constituents. Virology (1973) 0.95
Application of a solid-phase radioimmunoassay and immune electron microscopy for hepatitis A in diagnosis and research. Med Microbiol Immunol (1978) 0.93
[On the interpretation of cell wall structures in thin sections of gram-negative bacteria]. Zentralbl Bakteriol Orig (1965) 0.93
Cell culture models of human trophoblast II: trophoblast cell lines--a workshop report. Placenta (2001) 0.92
Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol (1994) 0.91
Synergism between ipratropium and theophylline in asthma. Thorax (1981) 0.91
Properties of mouse leukemia viruses. XV. Electron microscopic studies on the organization of Friend leukemia virus and other mammalian C-type viruses. Z Naturforsch C (1978) 0.91
Methotrexate-induced pulmonary disease. J Can Assoc Radiol (1973) 0.90
Anaerobic metabolism of carbon tetrachloride and formation of catabolically resistant phospholipids. Biochem Pharmacol (1984) 0.89
Time course of regression of left ventricular hypertrophy after successful parathyroidectomy. Surgery (1997) 0.89
Rapid gas chromatographic separation of amino acid enantiomers with a novel chiral stationary phase. J Chromatogr Sci (1977) 0.89
Assignment of the configurations of the amino acids in peptidic siderophores. J Chromatogr (1988) 0.89
Occult foreign-body aspiration in adults. JAMA (1982) 0.88
Electron microscopy of purified influenza virus neuraminidase. Virology (1968) 0.88
Carbon tetrachloride metabolism in vivo and exhalation of volatile alkanes: dependence upon oxygen partial pressure. Toxicology (1984) 0.88
Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials. Recent Results Cancer Res (1980) 0.88
Hepatitis A-virus particles in stools of patients from a natural hepatitis outbreak in Germany. Med Microbiol Immunol (1977) 0.88
[Liver and beer consumption. Comparative studies in 450 workers]. Munch Med Wochenschr (1967) 0.88
Magnetic resonance imaging of the heart during positive end-expiratory pressure ventilation in normal subjects. Crit Care Med (1994) 0.88
Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol (1999) 0.87
Metabolic activation of carbon tetrachloride: induction of cytochrome P-450 with phenobarbital or 3-methylcholanthrene and its effect on covalent binding. Chem Biol Interact (1982) 0.87
Intestinal calcium transport: stimulation by low phosphorus diets. Science (1973) 0.87
Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension. Am J Respir Crit Care Med (1994) 0.87
Chlorophyll a fluorescence: a tool for the investigation of toxic effects in the photosynthetic apparatus. Ecotoxicol Environ Saf (1998) 0.86
Chemotherapy and survival in breast cancer. Lancet (1980) 0.86
Characterization of acute renal failure in the burned patient. Arch Intern Med (1982) 0.85
[Cross-sectorial cooperation regarding cancer patients in a recently started care program. Ideas and themes based on focus group interviews with general practitioners and oncologists]. Ugeskr Laeger (1999) 0.84
Electropermeabilization and fluorescent tracer exchange: the role of whole-cell capacitance. Cytometry (1995) 0.84
Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Eur Heart J (1992) 0.84
Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P450IA2. Eur J Pharmacol (1992) 0.84
Phosphorylating proteins as effectors in malignant cell transformation. Adv Cyclic Nucleotide Res (1981) 0.84
A relationship between erythema multiforme and histoplasmosis. J Invest Dermatol (1965) 0.84
The solitary pulmonary nodule. Decision analysis. Med Decis Making (1985) 0.84
Estradiol binding protein in cystosarcoma phyllodes of the breast. Eur J Cancer (1980) 0.83
Association between coated vesicles and microtubules. Exp Cell Res (1983) 0.83
Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci (1997) 0.83
Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials. Eur J Cancer (1980) 0.83
Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cells. Carcinogenesis (1998) 0.83
Therapeutic effect of tamoxifen related to estrogen receptor level. Recent Results Cancer Res (1980) 0.83
Effect of transcendental meditation on breathing and respiratory control. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.83
Carotid plaque composition in chronic kidney disease: a retrospective analysis of patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg (2009) 0.83